DPP-IV is an enzyme that degrades GLP-1, a crucial incretin hormone involved in insulin secretion and glucose regulation, positioning DPP-IV inhibition as a key therapeutic target for diabetes. This evidence concerns the gene INS and diabetes mellitus.